An update on the genetics of Gilles de la Tourette syndrome

Journal of Psychosomatic Research

Volumn 55, Issue 1, 2003, Pages 7-12

  Pauls, David L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Candidate gene studies; Family studies; Genetic linkage studies; Gilles de la Tourette syndrome

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; GENE PRODUCT;

CHROMOSOME; CLINICAL FEATURE; FAMILIAL INCIDENCE; FAMILY STUDY; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC LINKAGE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC RISK; GENOME ANALYSIS; GILLES DE LA TOURETTE SYNDROME; HUMAN; INHERITANCE; PATHOGENESIS; REVIEW; RISK FACTOR; SEGREGATION ANALYSIS;

EID: 0042090498     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3999(02)00586-X     Document Type: Article

References (62)

1. Alsobrook JP, Pauls DL. A factor analysis of tic symptoms in Gilles de la Tourette's syndrome. Am J Psychiatry 2002;159:291-6.
2. Barr CL, Wigg KG, Pakstis AJ, Kurlan R, Pauls DL, Kidd KK, Tsui L-C, Sandor P. Genome scan for linkage to Gilles de la Tourette syndrome. Am J Med Genet 1999;88:437-45.
3. Barr CL, Wigg KG, Sandor P. Cathechol-O-methyltransferase and Gilles de la Tourette syndrome. Mol Psychiatry 1999;4(5):492-5.
4. Barr CL, Wigg KG, Zovko E, Sandor P, Tsui L-C. Linkage study of the dopamine D5 receptor gene and Gilles de la Tourette syndrome. Am J Med Genet (Neuropsychiatr Genet) 1997;74:58-61.
5. Barr CL, Wigg KG, Zovko E, Sandor P, Tsui L-C. No evidence for a major gene effect of the dopamine D4 receptor gene in the susceptibility to Gilles de la Tourette syndrome in five Canadian families. Am J Med Genet (Neuropsychiatr Genet) 1996;67:301-5.
6. Brett P, Curtis D, Robertson M, Gurling H. Exclusions of the 5-HT1A seratonin neuroreceptor and tryptophan oxygenase genes in a large British kindered multiply affected with Tourette's syndrome, chronic motor tics, and obssessive-compulsive behavior. Am J Psychiatry 1995;152:437-40.
7. Brett PM, Curtis D, Robertson MM, Dahlitz M, Gurling HM. Linkage analysis and exclusion of regions of chromosomes 3 and 8 in Gilles de la Tourette syndrome following the identification of a balanced reciprocal translocation 46 XY, t(3:8)(p21.3 q24.1) in a case of Tourette syndrome. Psychiatr Genet 1996;6:99-105.
8. Brett PM, Curtis D, Robertson MM, Gurling HM. Neuroreceptor subunit genes and the genetic susceptibility to Gilles de la Tourette syndrome. Biol Psychiatry 1997;42:941-7.
9. Carter AS, O'Donnell DA, Schultz RT, Scahill L, Leckman JF, Pauls DL. Social and emotional adjustment in children affected with Gilles de la Tourette's syndrome: Associations with ADHD and family functioning. J Child Psychol Psychiatry Allied Discipl 2000;41:215-23.
10. Carter AS, Paul DL, Leckman JF, Cohen DJ. A prospective longitudinal study of Gilles de la Tourette's syndrome. J Am Acad Child Adol Psychiatry 1994;33:377-85.
11. Cavallini MC, Di Bella D, Catalano M, Bellodi L. An association study 5-HTTLPR polymorphism, COMT polymorphism, and Tourette's syndrome. Psychiatry Res 2000;97(2-3):93-100.
12. Comings D, Comings B, Dietz G, et al. Evidence the Tourette syndrome gene is at 18q22.1. Proceedings of the VIIth International Congress of Human Genetics, Berlin, vol. 620, 1986.
13. Comings DE, Comings BG. A controlled study of Tourette syndrome. Am J Hum Genet 1987;41:701-838.
14. Comings DE, Comings BG, Muhleman D, Dietz G, Shahbahrami B, Tast D, Knell E, Kocsis P, Baumgarten R, Kovacs BW. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA 1991;266:1793-800.
15. Devlin B, Roeder K. Genomic control for association studies. Biometrics 1999;55:997-1004.
16. Devor EJ, Grandy DK, Civelli O, Litt M, Burgess AK, Isenberg KE, Van De Wetering BJ, Oostra B. Genetic linkage is excluded for the D2-dopamine receptor lambda HD2G1 and flanking loci on chromosome 11q22-q23 in Tourette syndrome. Hum Hered 1990:40(2):105-8.
17. Eapen V, Pauls DL, Robertson MM. Evidence for autosomal dominant transmission in Tourette's syndrome - United Kingdom Cohort Study. Br J Psychiatry 1993;162:593-6.
18. Eapen V, Robertson MM, Alsobrook JP, Pauls DL. Obsessive compulsive symptoms in Gilles de la Tourette's syndrome and obsessive compulsive disorder: Differences by diagnosis and family history. Am J Med Genet (Neuropsychiatr Genet) 1997;74:432-8.
19. Falk C, Rubinstein P. Haplotype relative risks: An easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 1987;51:227-33.
20. Gelernter J, Kennedy J, Grandy D, Civelli O, Pauls DL, Pakstis A, Kurlan R, Sunahara RK, Niznik HB, Seeman P, O'Dowd B, Kidd KK. Exclusion of close linkage of Gilles de la Tourette syndrome to D1 dopamine receptor. Am J Psychiatry 1993;150:449-53.
21. Gelernter J, Pakstis AJ, Pauls DL, Kurlan R, Gancher ST, Civelli O, Grandy D, Kidd KK. Gilles de la Tourette syndrome is not linked to D2 dopamine receptor. Arch Gen Psychiatry 1990;47:1073-7.
22. Gelernter J, Pauls DL, Leckman J, Kidd KK, Kurlan R. D2 dopamine receptor (DRD2) alleles do not influence severity of Tourette's syndrome: Results from four large kindreds. Arch Neurol 1994; 51: 397-400.
23. Gelernter J, Rao PA, Pauls DL, Hamblin MW, Sibley DR, Kidd KK. Assignment of the 5HT7 receptor gene (HTR7) to chromosome 10q and exclusion of genetic linkage with Tourette syndrome. Genomics 1995;26:207-9.
24. Grice DE, Leckman JF, Pauls DL, Kurlan R, Kidd KK, Pakstis AJ, Chang FM, Cohen DJ, Gelernter J. Linkage disequilibrium between an allele at the dopamine D4 receptor locus with Tourette's syndrome by the transmission disequilibrium test. Am J Hum Genet 1996;59:644-52.
25. Grigorenko EL, Pauls DL. Analytical methods applied to psychiatric genetics. In: Leboyer M, Bellivier F, editors. Psychiatry Genetics: Methods and Protocols. Totowa (NJ): Humana Press. pp. 23-61.
26. Hasstedt SJ, Leppert M, Filoux F, Van De Wetering BJM, McMahon Wm. Intermediate inheritance of Tourette syndrome, assuming assortative mating. Am J Hum Genet 1995;57:682-9.
27. Hebebrand J, Klug B, Fimmers R, Seuchter SA, Wettke-Schafer R, Deget F, Camps A, Lisch S, Hebebrand K, Von Gontard A, Lehmkuhl G, Poustka F, SChmidt M, Baur MP, Remschmidt H. Rates for tic disorders and obsessive compulsive symptomatology in families of children and adolescents with Gilles de la Tourette syndrome. J Psychiatr Res 1997;31:519-30.
28. Hebebrand J, Nöthen MM, Lehmkuhl G, Poustka F, Schmidt M, Propping P, Remschmidt H. Tourette's syndrome and homozygosity for the dopamine D3 receptor gene. German Tourette's Syndrome Collaborative Research Group. Lancet 1993;341:1483-4.
29. Heutink P, Van De Wetering BJM, Breedfeld G, Weber J, Sandkuyl LA, Devor EJ, Heiberg A, Niermeijer MF, Oostra BA. No evidence for genetic linkage of Gilles de la Tourette syndrome on chromosome 7 and 18. J Med Genet 1990;27:433-6.
30. Heutink P, Van De Wetering BJM, Pakstis AJ, Kurlan R, Sandor P, Oostra BA, Sandkuijl LA. Linkage studies on Gilles de la Tourette syndrome: What is the strategy of choice? Am Hum Genet 1995;57(2):465-73.
31. Kano Y, Ohta M, Nagai Y, Pauls DL, Leckman JF. A family study of Tourette syndrome in Japan. Am J Med Genet 2001;105(5):414-21.
32. Leckman JF, Dolnansky ES, Hardin M, Clubb M, Walkup JT, Stevenson J, Pauls DL. The perinatal factors in the expression of Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 1990:29:220-6.
33. Leckman JF, Price RA, Walkup JT, Ort S, Pauls DL, Cohen DJ. Birth-weights of monozygotic twins discordant for Tourette's syndrome. Arch Gen Psychiatry 1987;44:100.
34. Matsumoto N, David DE, Johnson EW, Konecki D, Burmester JK, Ledbetter DH, Weber JL. Breakpoint sequences of an 1;8 translocation in a family with Gilles de la Tourette syndrome. Eur J Hum Genet 2000;8:87-83.
35. Merette C, Brassard A, Potvin A, Bouvier H, Rousseau F, Emond C, Bissonnette L, Roy MA, Maziade M, Ott J, Caron C. Significant linkange for Tourette syndrome in a large French Canadian family. Am J Hum Genet 2000;67(4):1008-13.
36. Nöthen MM, Hebebrand J, Knapp M, Hebebrand K, Camps A, Von Gontard A, Wettke-Schafer R, Lisch S, Cichon S, Poustka F, et al. Association analysis of the dopamine D2 receptor gene in Tourette's syndrome using the haplotype relative risk method. Am J Med Genet 1994;54:249-52.
37. Pakstis AJ, Heutink P, Pauls DL, Kurlan R, Van De Wetering BJM, Leckman JF, Sandkuyl LA, Kidd JR, Breedveld GJ, Castiglione CM, Weber J, Sparkes RS, Cohen DJ, Kidd KK, Oostra BA. Progress in the search for genetic linkage with Tourette syndrome: An exclusion map covering more than 50% of the autosomal genome. Am J Hum Genet 1991;48:281-94.
38. Pauls DL, Alsobrook JP, Almasy L, Leckman JF, Cohen DJ. Genetic and epidemiological analyses of the Yale Tourette's Syndrome Family Study data. Psychiatr Genet 1991;2:28.
39. Pauls DL, Leckman JF, Cohen DJ. Evidence against a genetic relationship between Gilles de la Tourette's syndrome and anxiety, depression, panic and phobic disorders. Br J Psychiatry 1994;164:215-21.
40. Pauls DL, Leckman JF, Cohen DJ. The familial relationship between Gilles de la Tourette's syndrome, attention deficit disorder, learning disabilities, speech disorders and stuttering. J Am Acad Child Adolesc Psychiatry 1993;32:1044-50.
41. Pauls DL, Leckman JF. The inheritance of Gilles de la Tourette's syndrome and associated behaviors: Evidence for autosomal dominant transmission. N Engl J Med 1986;315:993-7.
42. Pauls DL, Pakstis AJ, Kurlan R, Kidd KK, Leckman JF, Cohen DJ, Kidd JR, et al. Segregation and linkage analyses of Tourette's syndrome and related disorders. J Am Acad Child Adolesc Psychiatry 1990;29:195-203.
43. Pauls DL, Raymond CL, Leckman JF, Stevenson JM. A family study of Tourette's syndrome. Am J Hum Genet 1991;48:154-63.
44. Pauls DL. Behavioural disorders: Lessons in linkage. Nat Genet 1993;3:4-5.
45. Pauls DL. Emerging genetic markers and their role in potential preventive intervention strategies. In: Muehrer P, editor. Conceptual Research Models for Preventing Mental Disorders. Rockville (MD): NIMH, 1990. pp. 184-95.
46. Petek E, Windpassinger C, Vincent JB, Cheung J, Boright AP, Scherer SW, Kroisel PM, Wagner K. Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome. Am J Hum Genet 2001;68(4):848-58.
47. Robertson MM, Stern JS. Tic disorders: New developments in Tourette syndrome and related disorders. Curr Opin Neurol 1998;11:373-80.
48. Santangelo SL, Pauls DL, Goldstein JM, Faraone SV, Tsuang MT, Leckman JF. Tourette syndrome: What are the influences of gender and co-morbid OCD? J Am Acad Child Adolesc Psychiatry 1994;33:795-804.
49. Santangelo SL, Pauls DL, Lavori PL, Goldstein JM, Faraone SV, Tsuang MT. Assessing risk for the Tourette spectrum of disorders among first degree relatives of probands with Tourette syndrome. Am J Med Genet (Neuropsychiatr Genet) 1996;67:107-16.
50. Schultz RT, Carter AS, Gladstone M, Scahill L, Leckman JF, Peterson BS, Zhang H, Cohen DJ, Pauls DL. Visual-motor integration, visuosperceptual and fine motor functioning in children with Tourette syndrome. Neuropsychology 1998;12:134-45.
51. Seuchter SA, Hebebrand J, Klug B, Knapp M, Lehmkuhl G, Poustka F, Schmidt M, Remschmidt H, Baur MP. Complex segregation analysis of families ascertained through Gilles de la Tourette syndrome. Genet Epidemiol 2000;18(1):33-47.
52. Simonic I, Gericke GS, Ott J, Weber JL. Identification of genetic markers associated with Gilles de la Tourette syndrome in an Afrikaner population. Am J Hum Gen 1998;63:839-46.
53. Simonic I, Nyholt DR, Gericke GS, Gordon D, Matsumoto N, Ledbetter DH, Ott J, Weber JL. Further evidence for linkage of Gilles de la Tourette syndrome (GTS) susceptibility loci on chromosomes 2p11, 8p22 and 11q23-24 in South African Afrikaners. Am J Med Genet 2001;105(32):163-7.
54. Spielman R, Ewens W. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996;59:983-9.
55. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993;52:506-16.
56. Stober G, Hebebrand J, Cichon S, Bruss M, Bonisch H, Lehmkuhl G, Poustka F, Schmidt M, Remschmidt H, Propping P, Nothen MM. Tourette syndrome and the norepinephrine transporter gene: Results of a systematic mutation screening. Am J Med Genet 1999;88(2):158-63.
57. Terwillinger JD, Ott J. A haplotype-based "haplotype relative risk" approach to detecting allelic associations. Hum Hered 1992;42:337-46.
58. The Tourette Syndrome Association International Consortium for Genetics. A complete genome screen in sib-pairs affected with the Gilles de la Tourette syndrome. Am J Hum Genet 1999;65:1428-36.
59. Van De Wetering BJM. A genetic study of Gilles de la Tourette syndrome in the Netherlands. PhD thesis, 1993.
60. Vandenbergh DJ, Thompson MD, Cook EH, Bendahhou E, Nguyen T, Krasowski MD, Zarrabian D, Comings D, Sellers EM, Tyndale RF, George SR, O'Dowd BF, Uhl GR. Human dopamine transporter gene: Coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations. Mol Psychiatry 2000;5(2):283-92.
61. Walkup JT, LaBuda MC, Singer HS, Brown J, Riddle MA, Hurko O. Family study and segregation analysis of Tourette syndrome: Evidence for a mixed model of inheritance. Am J Hum Genet 1996;59:684-93.
62. Yuan B, Vaske D, Weber JL, Beck J, Sheffield VC. Improved set of short-tandem-repeat polymorphisms for screening the human genome. Am J Hum Genet 1997;60:459-60.